Compare
Dotmatics vs Revvity Signals
Both are enterprise scientific informatics suites for pharma R&D; Dotmatics grew by acquiring products, Revvity Signals carries over PerkinElmer's Signals line.
Side by side
| Dotmatics | Revvity Signals | |
|---|---|---|
| Vendor | Dotmatics (Insight Partners) | Revvity Signals Software |
| Pricing model | Quote only | Quote only |
| Free tier | No | No |
| Deployment | Cloud, Self-hosted | Cloud |
| Open source | No | No |
| Best for | Pharma, biotech and chemical R&D organizations needing one connected platform across chemistry, biology and lab data. | Pharmaceutical and biotech R&D teams needing an enterprise ELN connected to biology and chemistry data. |
| Pricing | Enterprise contracts configured per organization; no public pricing. Pricing has not been verified yet — see the vendor's site. | Enterprise SaaS sold through direct sales, configured per customer; no public pricing. Pricing has not been verified yet — see the vendor's site. |
| Features |
|
|
Verdict
Dotmatics and Revvity Signals compete for the same buyer: a pharma, biotech or chemical R&D organization that needs to connect ELN, LIMS, sample/chemical data and instrument data across many teams, not a single lab's notebook. Both are sold as configured enterprise contracts with no public pricing, and both trace their current form to consolidation — Dotmatics built its suite by acquiring and integrating several separate products, backed by Insight Partners, while Revvity Signals is the scientific-software division carried over from PerkinElmer's Signals line after PerkinElmer split into Revvity (life sciences/diagnostics) and an applied-instruments business in 2023. The practical difference between them comes down to which existing systems and instrument landscape each already integrates with in your organization, which is a question no comparison page can answer generically.
Choose Dotmatics if
- Chemical registration and cross-discipline (chemistry-plus-biology) data connection is a core requirement, not an add-on.
- You want both cloud and self-hosted deployment options.
- Your organization already uses other tools from Dotmatics' acquired product lineup.
Choose Revvity Signals if
- You are already a PerkinElmer or Revvity instrument customer and want continuity with the Signals product line you know.
- In vitro/in vivo study data tools (Signals VitroVivo) matter to your specific research workflows.
- A pure enterprise SaaS deployment fits your infrastructure needs better than a self-hosted option.
What they share
Both are targeted squarely at pharmaceutical and biotech R&D rather than a single academic lab, both bundle electronic lab notebooking with broader data capture and analysis rather than selling a notebook alone, and both expect an implementation project rather than a self-serve signup — this is not software you evaluate by starting a free trial. If your organization is smaller than either vendor's typical customer, a combined but lighter platform such as Labguru or Sapio Sciences may be a better-sized fit than either enterprise suite.
The honest caveat
Neither vendor publishes pricing, and both are sold through a direct-sales, configure-to-your-workflow process — meaning the real comparison only becomes clear after a demo and a proposal scoped to your instrument landscape, user count and compliance needs. Do not shortlist either based on feature lists alone; ask each vendor for reference customers in your specific R&D discipline (chemistry-heavy versus biology-heavy) and weigh implementation timeline as heavily as the feature comparison.
Last reviewed September 22, 2026